Live Markets
Tuesday, July 28, 2026·George Town, KY·29°·Partly Cloudy
Markets Open · NYSE·Newsletter·Masthead·
VOL. XII · NO. 117Established MMXIV · George Town, Grand CaymanAtlantic Edition · $4.50

The Cayman Journal

Finance · Business · Technology · Caribbean & Global Affairs
Markets · Healthcare

Medtronic plc (MDT)

NYQ · Medical Devices

$86.88+2.66 (+3.16%)Quote refreshed

Sources: Yahoo Finance (quote, statistics) · SEC EDGAR (filings, insider trades, 13F holders) · company filings & press wires

Market Cap
$111.21B
P/E (TTM)
22.57
EPS
$3.85
Div Yield
3.42%
52W Range
$73.31–$106.33
Beta
0.58

Company overview

Next earnings: 2026-09-01(35d)

Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients in the United States, Ireland, and internationally. It operates through three segments: The Cardiovascular Portfolio, Neuroscience Portfolio, and Medical Surgical Portfolio. The Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac monitor systems; TYRX products; and remote monitoring and patient-centered software. It also provides aortic valves, surgical valve replacement and repair products, endovascular stent grafts and accessories, and transcatheter pulmonary valves, left atrial appendage exclusion systems, extracorporeal membrane oxygenation (ECMO) systems and percutaneous coronary intervention products, percutaneous angioplasty balloons, and endovenous products. The Neuroscience Portfolio segment offers medical devices and implants, biologic solutions, spinal cord stimulation and brain modulation systems, implantable drug infusion systems, and interventional products, as well as nerve ablation system under the Accurian name. This segment offers its products for spinal surgeons, neurosurgeons, neurologists, pain management specialists, anesthesiologists, orthopedic surgeons, urologists, urogynecologists, and interventional radiologists, as well as ear, nose, and throat specialists, and energy surgical instruments. The Medical Surgical Portfolio segment offers surgical stapling devices, vessel sealing instruments, wound closure and electrosurgery products, AI-powered surgical video and analytics platform, robotic-assisted surgery products, hernia mechanical devices, mesh implants, gynecology products, gastrointestinal and hepatologic diagnostics and therapies, and therapies to treat diseases and conditions, and patient monitoring and airway management products, as well as insulin pumps and consumables, continuous glucose monitoring systems, and sensors. Medtronic plc was founded in 1949 and is headquartered in Galway, Ireland.

Peers in Medical Devices

All in industry →

Recent press releases

Medtronic plc has not issued a press release in this window.

SEC filings

All filings →

Medtronic plc has not filed an SEC document in this window.

Medtronic plc has no reported insider trades in the last 90 days.

Institutional holders

All holders →
As of 2025-12-31 · prior 2025-09-30
14,030,830 sh-41.8%
4,641,969 sh-60.4%
34,573,163 sh+12.6%
3,339,011 sh-51.1%
17,213,042 sh+18.7%
13,359,367 sh+31.1%
128,961,343 sh+1.5%
3,218,852 sh-45.7%

People at Medtronic plc

All people →

Quarterly financials

Full financials →
Revenue trend
01/25
NI $1.29B
07/25
$471.0M
NI $1.04B
10/25
$8.96B
NI $1.37B
RevenueNI = Net Income
EPS trend (diluted)
Latest: $1.07
Prior: $0.81
Revenue sparkline